Zeria Pharmaceutical Co., Ltd. (TYO:4559)
Japan · Delayed Price · Currency is JPY 2,235.00
+43.00 (1.96%)
At close: Mar 27, 2026
Zeria Pharmaceutical Market Cap
Zeria Pharmaceutical has a market cap or net worth of 96.28 billion as of March 27, 2026. Its market cap has increased by 2.21% in one year.
Market Cap
96.28B
Enterprise Value
113.19B
Revenue
86.61B
Ranking
n/a
PE Ratio
13.56
Stock Price
2,235.00
Market Cap Chart
Since December 22, 1998, Zeria Pharmaceutical's market cap has increased from 58.12B to 96.28B, an increase of 65.67%. That is a compound annual growth rate of 1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 96.28B | 4.06% |
| Dec 30, 2025 | 92.52B | -14.05% |
| Dec 30, 2024 | 107.64B | 21.07% |
| Dec 29, 2023 | 88.91B | -11.00% |
| Dec 30, 2022 | 99.90B | 12.78% |
| Dec 30, 2021 | 88.58B | 0.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sawai Group Holdings | 253.14B |
| Towa Pharmaceutical | 196.67B |
| Kissei Pharmaceutical | 190.68B |
| Kaken Pharmaceutical | 157.72B |
| Mochida Pharmaceutical | 129.75B |
| KYORIN Pharmaceutical | 94.61B |
| ASKA Pharmaceutical Holdings | 65.40B |
| Fuji Pharma | 61.40B |